Fulgent Genetics (FLGT) Cash & Equivalents Growth (3y) (2018 - 2026)
Fulgent Genetics (FLGT) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 70.63% |
| 10 | Fulgent Genetics | 515.57 Mn | 258.54 Mn | 25.68 Mn | -23.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.32% |
| Mar 31, 2026 | -29.29% |
| Dec 31, 2025 | -14.21% |
| Sep 30, 2025 | -11.33% |
| Jun 30, 2025 | 25.74% |
| Mar 31, 2025 | -13.90% |
| Dec 31, 2024 | -30.59% |
| Sep 30, 2024 | -35.36% |
| Jun 30, 2024 | 127.90% |
| Mar 31, 2024 | -28.80% |
| Dec 31, 2023 | 3.69% |
| Sep 30, 2023 | 30.19% |
| Jun 30, 2023 | 114.48% |
| Mar 31, 2023 | 156.03% |
| Dec 31, 2022 | 88.00% |
| Sep 30, 2022 | 101.85% |
| Jun 30, 2022 | 68.96% |
| Mar 31, 2022 | 495.17% |
| Dec 31, 2021 | 190.36% |
| Sep 30, 2021 | 256.92% |